1 / 6

Managing Prize Systems

Managing Prize Systems. Maastricht January 2008 Ron Marchant CB FRSA. Managing Prize Systems: Outline. Objective Access to medical treatment for those suffering from diseases not currently targeted Distinctions Requirements Consequences A possibility?. Distinctions.

zurina
Télécharger la présentation

Managing Prize Systems

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Managing Prize Systems Maastricht January 2008 Ron Marchant CB FRSA

  2. Managing Prize Systems: Outline • Objective • Access to medical treatment for those suffering from diseases not currently targeted • Distinctions • Requirements • Consequences • A possibility?

  3. Distinctions • Specific diseases or developing countries • National or global approach • Private or government • Voluntary or compulsory • Ideological or practical • Patent or non-patent • Consumers or producers • Whim or stable

  4. Requirements • Attractive to participants • Research to commercialisation • Reflects priorities • Acceptable to government • Meet innovation paradigm

  5. Consequences • Size, timing, and predictability of reward • Minimal regulatory burden • Governance • Transparency • Accountability • Public money • Agree programmes • Room for one-offs • Management of IP • Recognise incremental innovation • Control substitute behaviours

  6. A possibility • Grant plus prize plus patent • Phased payment from project specification to delivery • Conditions • Pharma, large or small • Research developing plus developed • Patent licence of right • Managed by WHO? • Result • Tech transfer • Broad priority setting • Sidelines IP debate

More Related